iCAD’s Breast AI Suite Wins U.S. General Services Administration’s AI Healthcare Challenge Award

May 18, 2023
Category: Press Releases

Company presented portfolio of breast cancer detection, density assessment and risk evaluation solutions at the competition, focused on improving health outcomes

 

NASHUA, N.H., May 18, 2023 – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced its Breast AI Suite is a winner of the U.S. General Services Administration’s (GSA) “AI Healthcare Challenge” award. iCAD presented its portfolio of breast cancer detection, density assessment and risk evaluation solutions at the competiti... Continue reading

Tags: press releases

iCAD Reports Financial Results for First Quarter Ended March 31, 2023

May 15, 2023
Category: Press Releases

Company to host conference call and webcast today at 4:30 PM ET 

 

NASHUA, N.H. – May 15, 2023 – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today reported its financial and operating results for the three months ended March 31, 2023. 

 

Highlights:


Body of evidence supporting iCAD’s technologies grows, with compelling new research supporting Company’s Breast AI Suite and... Continue reading
Tags: press releases

New Long-Term Real-World Research Confirms Xoft Skin eBx is as Safe and Effective as Mohs Surgery

May 11, 2023
Category: Press Releases

98.9% of patients treated with Xoft remained recurrence-free at a median follow-up of 7.6 years, according to recent study published in Journal of Contemporary Brachytherapy

 

NASHUA, N.H., May 11, 2023 – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced compelling new long-term real-world research confirms Xoft Skin eBx is as safe and effective as Mohs surgery for the treatment of non-melanoma skin cancer (NMSC). In the longest-term study of Xof... Continue reading

Tags: press releases

iCAD Showcases Breast AI Suite at Society of Breast Imaging Symposium, World’s Largest Breast Imaging Conference

May 03, 2023
Category: Press Releases

iCAD’s AI solution minimizes interval cancers and overcomes challenges associated with digital breast tomosynthesis

 

NASHUA, N.H., May 3, 2023 – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced it will showcase its Breast AI Suite of cancer detection, density assessment and risk evaluation solutions at the world’s largest breast imaging conference, the Society of Breast Imaging (SBI) Symposium, taking place May 4-7 in National Harbor, MD. Attendees are i... Continue reading

Tags: press releases

iCAD to Report First Quarter 2023 Financial Results on May 15, 2023

May 01, 2023
Category: Press Releases

NASHUA, N.H., May 1, 2023 -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will release financial results for the first quarter ended March 31, 2023, after the market close, and host a conference call at 4:30 PM Eastern Time on Monday, May 15, 2023.

 

Earnings call details are as follows:

 

Domestic: 877-545-0523

International: 973-528-0016

Continue reading

Tags: press releases

iCAD’s “ProFound Insights, ProFound Impact” Webinar Series to Feature Boca Raton Regional Hospital

April 25, 2023
Category: Press Releases

Kathy Schilling, MD, Boca Raton Regional Hospital, to discuss how ProFound AI helped nine dedicated breast radiologists find 23% more cancers, without increasing the rate of recalls

 

NASHUA, N.H., April 25, 2023 – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced its “ProFound Insights, ProFound Impact” webinar series will feature Kathy Schilling, MD, Medical Director, Christine E. Lynn Women's Health & Wellness Institute, Boca Raton Regional Hospital. The live event,... Continue reading

Tags: press releases

New and Real-World Clinical Evidence Confirms ProFound AI Increases Cancer Detection and Reveals Critical Clues to Inform Clinical Decisions

April 20, 2023
Category: Press Releases

New research presented at American Roentgen Ray Society (ARRS) meeting continues to validate unique value iCAD’s deep-learning breast AI solution offers to clinicians and patients

   

NASHUA, N.H., April 20, 2023 – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced new real-world research confirms ProFound AI® has been proven to increase cancer detection rates and provide vital clues for breast imagers' clinical decisions through two studies. One... Continue reading

Tags: Press Releases

iCAD Strengthens Leadership Team with Appointment of Chief Financial Officer and New Senior Executives

April 17, 2023
Category: Press Releases

Eric Lonnqvist as Chief Financial Officer, Vasu Avadhanula as Chief Product Officer, and Michelle Strong as Chief Operations Officer bolster the Company’s executive leadership team and accelerate the Company’s growth strategies

 

NASHUA, N.H., April 17, 2023 – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the Board of Directors has approved the appointment of Eric Lonnqvist as Chief Financial Officer (CFO), effective immediately, as well as Vasu Avadhanula as Chief Pro... Continue reading

Tags: Press Releases

ProFound AI Risk Outperforms Traditional, Widely-Accepted Breast Cancer Risk Models for Both Short-term and Long-term Risk Assessments

April 04, 2023
Category: Press Releases

ProFound AI Risk offered higher accuracy than Tyrer-Cuzick v8 for all women, regardless of menopausal status, breast density, and family history of breast cancer

 

NASHUA, N.H., April 4, 2023 – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced new clinical evidence published in the Journalof Clinical Oncology found ProFound AI® Risk for 2D Mammography is more accurate than Tyrer-Cuzick v8, a commonly used lifestyle risk model, for both short-term... Continue reading

Tags: Press Releases

iCAD Reports Financial Results for Fourth Quarter ended December 31, 2022 and Year End

March 28, 2023
Category: Press Releases

     Strategy focused on profitability by end of 2024, using current cash on hand

New leadership to host conference call and webcast today at 4:30 PM ET

 

NASHUA, N.H. – March 28, 2023 – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today reported its financial and operating results for the twelve months ended December 31, 2022.

 

Highlig... Continue reading

Tags: Press Releases

iCAD’s Breast AI Suite Empowers Customers to Lead the Way in Support of FDA’s National Breast Density Reporting Standard

March 23, 2023
Category: Press Releases

iCAD showcases Breast AI Suite at National Consortium of Breast Centers (NCoBC) 32nd Annual Conference 

 

NASHUA, N.H., March 23, 2023 – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced its technologies are empowering customers to lead the way in breast care, while supporting the national breast density reporting standard recently established by the U.S. Food and Drug Administration (FDA). The Company will be showcasing its Breast AI Suite... Continue reading

Tags: Press Releases

iCAD Previews Fourth Quarter Financial Results, Full Report on March 28, 2023

March 13, 2023
Category: Press Releases

Company is exploring strategic options for its Therapy business line

 

NASHUA, N.H., March 13, 2023 -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will release financial results for the fourth quarter and year ended December 31, 2022, after the market close, and host a conference call at 4:30 PM ET on Tuesday, March 28, 2023.

 

Based on preliminary, unaudited financial infor... Continue reading

Tags: Press Releases

iCAD Announces Leadership Transition

March 13, 2023
Category: Press Releases

Stacey Stevens Resigns as President and CEO and as a Member of the Board


Dana Brown Named President and CEO, remains Chairman of the Board


NASHUA, N.H. – March 13, 2023 – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the Board of Directors has accepted the resignation, for personal reasons, of Stacey Stevens as President and CEO. Stacey will remain with the Company through Apr... Continue reading

Tags: Press Releases

New Real-World Clinical Evidence Confirms ProFound AI Boosts Radiologists' Efficiency and Accuracy

March 01, 2023
Category: Press Releases

Company’s Breast AI Suite of deep-learning breast cancer detection, density assessment and risk evaluation tools showcased at ECR 2023

 

NASHUA, N.H. – March 1, 2023 – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced new real-world clinical evidence to be presented at the European Congress of Radiology (ECR) 2023 meeting confirms ProFound AI® boosts radiologists’ efficiency and accuracy. The Company is also showcasing its Breast AI Suite of deep... Continue reading

Tags: Press Releases

iCAD to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference

February 09, 2023
Category: Press Releases

NASHUA, N.H., February 9, 2023 -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the Company will participate in the BTIG Snowbird MedTech, Digital Health, Life Science & Diagnostic Tools Conference from February 14-16, 2023 in Snowbird, UT.

 

Stacey Stevens, President and CEO of iCAD, Inc., will participate in one-on-one meetings with investors at the event. Please contact your BTIG representative for further information or to request a meeting.

Continue reading

Tags: Press Releases

iCAD Announces CFO Transition and Hires New Senior Vice President, US Commercial Sales, AI

January 23, 2023
Category: Press Releases

Daniel Shea appointed as interim Chief Financial Officer

 

William Keyes hired as Senior Vice President, US Commercial Sales, AI

 

NASHUA, N.H. – January 23, 2023 - iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the Board of Directors has approved the appointment of Daniel Shea, CPA, as interim Chief Financial Officer (CFO), effective immediately. The Company has launched a search for a full-time CFO, with the goal... Continue reading

Tags: Press Releases

iCAD Announces Board of Directors Transition

January 11, 2023
Category: Press Releases

Dana Brown named Executive Chair of the Board  

 

NASHUA, N.H. – January 11, 2023 - iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the appointment of Dana Brown as Executive Chair of the Board of Directors. Ms. Brown has been a non-executive board member since February 2022. Prior to joining iCAD’s board, Ms. Brown was the Senior Vice President, Chief Strategy and Operations Officer for... Continue reading

Tags: Press Releases

iCAD features Solis Mammography in upcoming “ProFound Insights, ProFound Impact” webinar

December 08, 2022
Category: Press Releases

Solis Mammography’s Chief Medical Officer Chirag Parghi, MD, to share clinical experience and real-world case studies demonstrating clinical value of ProFound AI

 

NASHUA, N.H. – December 5, 2022 - iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced Solis Mammography, the largest independent provider of breast screening and diagnostic services in the United States, will be featured in the next “ProFound Insights, ProFound Impact” webinar, on Dec. 14 at 3 pm EST / 12 pm P... Continue reading

Tags: Press Releases

iCAD and Google Health Ink Strategic Development and Commercialization Agreement

November 28, 2022
Category: Press Releases

Google Health AI and Cloud technology to be integrated into iCAD’s portfolio with potential to elevate performance and expand access to millions of women worldwide

 

Agreement marks Google Health’s first partnership with a mammography AI vendor

 

NASHUA, N.H. – November 28, 2022 - iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced a strategic development... Continue reading

Tags: Press Releases

Positive New Research Presented at RSNA 2022 Reaffirms iCAD’s Breast AI Suite Improves Radiologists’ Performance and Breast Cancer Detection

November 21, 2022
Category: Press Releases

Study affirms utility of ProFound AI’s Case Scores in improving cancer detection

 

Company’s Breast AI Suite of deep-learning breast cancer detection, density assessment and risk evaluation tools showcased at largest medical imaging forum in the world

 

NASHUA, N.H. – November 21, 2022 – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced new and real-world research demonstrating the value of its Breast AI Suit... Continue reading

Tags: Press Releases

© iCAD Inc.  All rights reserved.  iCAD, the iCAD logo, PowerLook, ProFound AI, ProFound, Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are registered trademarks of iCAD, Inc. Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.

Facebook icon Twitter icon LinkedIn icon